1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Huntington’s Disease Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Huntington’s Disease Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Huntington’s Disease Treatment by Country/Region, 2018, 2022 & 2029
2.2 Huntington’s Disease Treatment Segment by Type
2.2.1 Tetrabenazine
2.2.2 Selective Serotonin Reuptake Inhibitor
2.2.3 Chlorpromazine
2.2.4 Haloperidol
2.2.5 Risperidone
2.2.6 Olanzapine
2.2.7 Clozapine
2.2.8 Other
2.3 Huntington’s Disease Treatment Sales by Type
2.3.1 Global Huntington’s Disease Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Huntington’s Disease Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Huntington’s Disease Treatment Sale Price by Type (2018-2023)
2.4 Huntington’s Disease Treatment Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 other
2.5 Huntington’s Disease Treatment Sales by Application
2.5.1 Global Huntington’s Disease Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Huntington’s Disease Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Huntington’s Disease Treatment Sale Price by Application (2018-2023)
3 Global Huntington’s Disease Treatment by Company
3.1 Global Huntington’s Disease Treatment Breakdown Data by Company
3.1.1 Global Huntington’s Disease Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Huntington’s Disease Treatment Sales Market Share by Company (2018-2023)
3.2 Global Huntington’s Disease Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Huntington’s Disease Treatment Revenue by Company (2018-2023)
3.2.2 Global Huntington’s Disease Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Huntington’s Disease Treatment Sale Price by Company
3.4 Key Manufacturers Huntington’s Disease Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Huntington’s Disease Treatment Product Location Distribution
3.4.2 Players Huntington’s Disease Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Huntington’s Disease Treatment by Geographic Region
4.1 World Historic Huntington’s Disease Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Huntington’s Disease Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Huntington’s Disease Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Huntington’s Disease Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Huntington’s Disease Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Huntington’s Disease Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Huntington’s Disease Treatment Sales Growth
4.4 APAC Huntington’s Disease Treatment Sales Growth
4.5 Europe Huntington’s Disease Treatment Sales Growth
4.6 Middle East & Africa Huntington’s Disease Treatment Sales Growth
5 Americas
5.1 Americas Huntington’s Disease Treatment Sales by Country
5.1.1 Americas Huntington’s Disease Treatment Sales by Country (2018-2023)
5.1.2 Americas Huntington’s Disease Treatment Revenue by Country (2018-2023)
5.2 Americas Huntington’s Disease Treatment Sales by Type
5.3 Americas Huntington’s Disease Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Huntington’s Disease Treatment Sales by Region
6.1.1 APAC Huntington’s Disease Treatment Sales by Region (2018-2023)
6.1.2 APAC Huntington’s Disease Treatment Revenue by Region (2018-2023)
6.2 APAC Huntington’s Disease Treatment Sales by Type
6.3 APAC Huntington’s Disease Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Huntington’s Disease Treatment by Country
7.1.1 Europe Huntington’s Disease Treatment Sales by Country (2018-2023)
7.1.2 Europe Huntington’s Disease Treatment Revenue by Country (2018-2023)
7.2 Europe Huntington’s Disease Treatment Sales by Type
7.3 Europe Huntington’s Disease Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Huntington’s Disease Treatment by Country
8.1.1 Middle East & Africa Huntington’s Disease Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Huntington’s Disease Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Huntington’s Disease Treatment Sales by Type
8.3 Middle East & Africa Huntington’s Disease Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Huntington’s Disease Treatment
10.3 Manufacturing Process Analysis of Huntington’s Disease Treatment
10.4 Industry Chain Structure of Huntington’s Disease Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Huntington’s Disease Treatment Distributors
11.3 Huntington’s Disease Treatment Customer
12 World Forecast Review for Huntington’s Disease Treatment by Geographic Region
12.1 Global Huntington’s Disease Treatment Market Size Forecast by Region
12.1.1 Global Huntington’s Disease Treatment Forecast by Region (2024-2029)
12.1.2 Global Huntington’s Disease Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Huntington’s Disease Treatment Forecast by Type
12.7 Global Huntington’s Disease Treatment Forecast by Application
13 Key Players Analysis
13.1 AInylam Pharmaceuticals Inc
13.1.1 AInylam Pharmaceuticals Inc Company Information
13.1.2 AInylam Pharmaceuticals Inc Huntington’s Disease Treatment Product Portfolios and Specifications
13.1.3 AInylam Pharmaceuticals Inc Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AInylam Pharmaceuticals Inc Main Business Overview
13.1.5 AInylam Pharmaceuticals Inc Latest Developments
13.2 AmpliPhi Biosciences Corp
13.2.1 AmpliPhi Biosciences Corp Company Information
13.2.2 AmpliPhi Biosciences Corp Huntington’s Disease Treatment Product Portfolios and Specifications
13.2.3 AmpliPhi Biosciences Corp Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AmpliPhi Biosciences Corp Main Business Overview
13.2.5 AmpliPhi Biosciences Corp Latest Developments
13.3 Ceregene Inc
13.3.1 Ceregene Inc Company Information
13.3.2 Ceregene Inc Huntington’s Disease Treatment Product Portfolios and Specifications
13.3.3 Ceregene Inc Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ceregene Inc Main Business Overview
13.3.5 Ceregene Inc Latest Developments
13.4 Lundbeck
13.4.1 Lundbeck Company Information
13.4.2 Lundbeck Huntington’s Disease Treatment Product Portfolios and Specifications
13.4.3 Lundbeck Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lundbeck Main Business Overview
13.4.5 Lundbeck Latest Developments
13.5 Prana Biotechnology Limited
13.5.1 Prana Biotechnology Limited Company Information
13.5.2 Prana Biotechnology Limited Huntington’s Disease Treatment Product Portfolios and Specifications
13.5.3 Prana Biotechnology Limited Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Prana Biotechnology Limited Main Business Overview
13.5.5 Prana Biotechnology Limited Latest Developments
13.6 Teva Pharmaceutical Industries Ltd
13.6.1 Teva Pharmaceutical Industries Ltd Company Information
13.6.2 Teva Pharmaceutical Industries Ltd Huntington’s Disease Treatment Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries Ltd Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.6.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.7 Cortex Pharmaceuticals Inc
13.7.1 Cortex Pharmaceuticals Inc Company Information
13.7.2 Cortex Pharmaceuticals Inc Huntington’s Disease Treatment Product Portfolios and Specifications
13.7.3 Cortex Pharmaceuticals Inc Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cortex Pharmaceuticals Inc Main Business Overview
13.7.5 Cortex Pharmaceuticals Inc Latest Developments
13.8 Vertex Pharmaceuticals Incorporated
13.8.1 Vertex Pharmaceuticals Incorporated Company Information
13.8.2 Vertex Pharmaceuticals Incorporated Huntington’s Disease Treatment Product Portfolios and Specifications
13.8.3 Vertex Pharmaceuticals Incorporated Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Vertex Pharmaceuticals Incorporated Main Business Overview
13.8.5 Vertex Pharmaceuticals Incorporated Latest Developments
13.9 Auspex Pharmaceuticals
13.9.1 Auspex Pharmaceuticals Company Information
13.9.2 Auspex Pharmaceuticals Huntington’s Disease Treatment Product Portfolios and Specifications
13.9.3 Auspex Pharmaceuticals Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Auspex Pharmaceuticals Main Business Overview
13.9.5 Auspex Pharmaceuticals Latest Developments
13.10 SOM Biotech
13.10.1 SOM Biotech Company Information
13.10.2 SOM Biotech Huntington’s Disease Treatment Product Portfolios and Specifications
13.10.3 SOM Biotech Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SOM Biotech Main Business Overview
13.10.5 SOM Biotech Latest Developments
13.11 GlaxoSmithKline
13.11.1 GlaxoSmithKline Company Information
13.11.2 GlaxoSmithKline Huntington’s Disease Treatment Product Portfolios and Specifications
13.11.3 GlaxoSmithKline Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 GlaxoSmithKline Main Business Overview
13.11.5 GlaxoSmithKline Latest Developments
13.12 Siena Biotech
13.12.1 Siena Biotech Company Information
13.12.2 Siena Biotech Huntington’s Disease Treatment Product Portfolios and Specifications
13.12.3 Siena Biotech Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Siena Biotech Main Business Overview
13.12.5 Siena Biotech Latest Developments
13.13 Raptor Pharmaceutical
13.13.1 Raptor Pharmaceutical Company Information
13.13.2 Raptor Pharmaceutical Huntington’s Disease Treatment Product Portfolios and Specifications
13.13.3 Raptor Pharmaceutical Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Raptor Pharmaceutical Main Business Overview
13.13.5 Raptor Pharmaceutical Latest Developments
13.14 Pfizer
13.14.1 Pfizer Company Information
13.14.2 Pfizer Huntington’s Disease Treatment Product Portfolios and Specifications
13.14.3 Pfizer Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Pfizer Main Business Overview
13.14.5 Pfizer Latest Developments
13.15 Palobiofarma
13.15.1 Palobiofarma Company Information
13.15.2 Palobiofarma Huntington’s Disease Treatment Product Portfolios and Specifications
13.15.3 Palobiofarma Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Palobiofarma Main Business Overview
13.15.5 Palobiofarma Latest Developments
13.16 Omeros
13.16.1 Omeros Company Information
13.16.2 Omeros Huntington’s Disease Treatment Product Portfolios and Specifications
13.16.3 Omeros Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Omeros Main Business Overview
13.16.5 Omeros Latest Developments
13.17 Ipsen
13.17.1 Ipsen Company Information
13.17.2 Ipsen Huntington’s Disease Treatment Product Portfolios and Specifications
13.17.3 Ipsen Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Ipsen Main Business Overview
13.17.5 Ipsen Latest Developments
13.18 Valeant Pharmaceuticals International Inc
13.18.1 Valeant Pharmaceuticals International Inc Company Information
13.18.2 Valeant Pharmaceuticals International Inc Huntington’s Disease Treatment Product Portfolios and Specifications
13.18.3 Valeant Pharmaceuticals International Inc Huntington’s Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Valeant Pharmaceuticals International Inc Main Business Overview
13.18.5 Valeant Pharmaceuticals International Inc Latest Developments
14 Research Findings and Conclusion
Table 1. Huntington's Disease Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Huntington's Disease Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tetrabenazine
Table 4. Major Players of Selective Serotonin Reuptake Inhibitor
Table 5. Major Players of Chlorpromazine
Table 6. Major Players of Haloperidol
Table 7. Major Players of Risperidone
Table 8. Major Players of Olanzapine
Table 9. Major Players of Clozapine
Table 10. Major Players of Other
Table 11. Global Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 12. Global Huntington's Disease Treatment Sales Market Share by Type (2018-2023)
Table 13. Global Huntington's Disease Treatment Revenue by Type (2018-2023) & ($ million)
Table 14. Global Huntington's Disease Treatment Revenue Market Share by Type (2018-2023)
Table 15. Global Huntington's Disease Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 16. Global Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 17. Global Huntington's Disease Treatment Sales Market Share by Application (2018-2023)
Table 18. Global Huntington's Disease Treatment Revenue by Application (2018-2023)
Table 19. Global Huntington's Disease Treatment Revenue Market Share by Application (2018-2023)
Table 20. Global Huntington's Disease Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 21. Global Huntington's Disease Treatment Sales by Company (2018-2023) & (K Units)
Table 22. Global Huntington's Disease Treatment Sales Market Share by Company (2018-2023)
Table 23. Global Huntington's Disease Treatment Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Huntington's Disease Treatment Revenue Market Share by Company (2018-2023)
Table 25. Global Huntington's Disease Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 26. Key Manufacturers Huntington's Disease Treatment Producing Area Distribution and Sales Area
Table 27. Players Huntington's Disease Treatment Products Offered
Table 28. Huntington's Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Huntington's Disease Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 32. Global Huntington's Disease Treatment Sales Market Share Geographic Region (2018-2023)
Table 33. Global Huntington's Disease Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Huntington's Disease Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Huntington's Disease Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 36. Global Huntington's Disease Treatment Sales Market Share by Country/Region (2018-2023)
Table 37. Global Huntington's Disease Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Huntington's Disease Treatment Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 40. Americas Huntington's Disease Treatment Sales Market Share by Country (2018-2023)
Table 41. Americas Huntington's Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Huntington's Disease Treatment Revenue Market Share by Country (2018-2023)
Table 43. Americas Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 44. Americas Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 45. APAC Huntington's Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 46. APAC Huntington's Disease Treatment Sales Market Share by Region (2018-2023)
Table 47. APAC Huntington's Disease Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Huntington's Disease Treatment Revenue Market Share by Region (2018-2023)
Table 49. APAC Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 50. APAC Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Europe Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Europe Huntington's Disease Treatment Sales Market Share by Country (2018-2023)
Table 53. Europe Huntington's Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Huntington's Disease Treatment Revenue Market Share by Country (2018-2023)
Table 55. Europe Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Europe Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Middle East & Africa Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 58. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Huntington's Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Huntington's Disease Treatment Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 62. Middle East & Africa Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 63. Key Market Drivers & Growth Opportunities of Huntington's Disease Treatment
Table 64. Key Market Challenges & Risks of Huntington's Disease Treatment
Table 65. Key Industry Trends of Huntington's Disease Treatment
Table 66. Huntington's Disease Treatment Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Huntington's Disease Treatment Distributors List
Table 69. Huntington's Disease Treatment Customer List
Table 70. Global Huntington's Disease Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 71. Global Huntington's Disease Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Huntington's Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Americas Huntington's Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Huntington's Disease Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 75. APAC Huntington's Disease Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Huntington's Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Europe Huntington's Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Huntington's Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 79. Middle East & Africa Huntington's Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Huntington's Disease Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 81. Global Huntington's Disease Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Huntington's Disease Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 83. Global Huntington's Disease Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. AInylam Pharmaceuticals Inc Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 85. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolios and Specifications
Table 86. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. AInylam Pharmaceuticals Inc Main Business
Table 88. AInylam Pharmaceuticals Inc Latest Developments
Table 89. AmpliPhi Biosciences Corp Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 90. AmpliPhi Biosciences Corp Huntington's Disease Treatment Product Portfolios and Specifications
Table 91. AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. AmpliPhi Biosciences Corp Main Business
Table 93. AmpliPhi Biosciences Corp Latest Developments
Table 94. Ceregene Inc Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceregene Inc Huntington's Disease Treatment Product Portfolios and Specifications
Table 96. Ceregene Inc Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Ceregene Inc Main Business
Table 98. Ceregene Inc Latest Developments
Table 99. Lundbeck Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. Lundbeck Huntington's Disease Treatment Product Portfolios and Specifications
Table 101. Lundbeck Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Lundbeck Main Business
Table 103. Lundbeck Latest Developments
Table 104. Prana Biotechnology Limited Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Prana Biotechnology Limited Huntington's Disease Treatment Product Portfolios and Specifications
Table 106. Prana Biotechnology Limited Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Prana Biotechnology Limited Main Business
Table 108. Prana Biotechnology Limited Latest Developments
Table 109. Teva Pharmaceutical Industries Ltd Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product Portfolios and Specifications
Table 111. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Teva Pharmaceutical Industries Ltd Main Business
Table 113. Teva Pharmaceutical Industries Ltd Latest Developments
Table 114. Cortex Pharmaceuticals Inc Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolios and Specifications
Table 116. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Cortex Pharmaceuticals Inc Main Business
Table 118. Cortex Pharmaceuticals Inc Latest Developments
Table 119. Vertex Pharmaceuticals Incorporated Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 120. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product Portfolios and Specifications
Table 121. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Vertex Pharmaceuticals Incorporated Main Business
Table 123. Vertex Pharmaceuticals Incorporated Latest Developments
Table 124. Auspex Pharmaceuticals Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 125. Auspex Pharmaceuticals Huntington's Disease Treatment Product Portfolios and Specifications
Table 126. Auspex Pharmaceuticals Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Auspex Pharmaceuticals Main Business
Table 128. Auspex Pharmaceuticals Latest Developments
Table 129. SOM Biotech Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 130. SOM Biotech Huntington's Disease Treatment Product Portfolios and Specifications
Table 131. SOM Biotech Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. SOM Biotech Main Business
Table 133. SOM Biotech Latest Developments
Table 134. GlaxoSmithKline Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 135. GlaxoSmithKline Huntington's Disease Treatment Product Portfolios and Specifications
Table 136. GlaxoSmithKline Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. GlaxoSmithKline Main Business
Table 138. GlaxoSmithKline Latest Developments
Table 139. Siena Biotech Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 140. Siena Biotech Huntington's Disease Treatment Product Portfolios and Specifications
Table 141. Siena Biotech Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Siena Biotech Main Business
Table 143. Siena Biotech Latest Developments
Table 144. Raptor Pharmaceutical Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 145. Raptor Pharmaceutical Huntington's Disease Treatment Product Portfolios and Specifications
Table 146. Raptor Pharmaceutical Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Raptor Pharmaceutical Main Business
Table 148. Raptor Pharmaceutical Latest Developments
Table 149. Pfizer Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 150. Pfizer Huntington's Disease Treatment Product Portfolios and Specifications
Table 151. Pfizer Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Pfizer Main Business
Table 153. Pfizer Latest Developments
Table 154. Palobiofarma Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 155. Palobiofarma Huntington's Disease Treatment Product Portfolios and Specifications
Table 156. Palobiofarma Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Palobiofarma Main Business
Table 158. Palobiofarma Latest Developments
Table 159. Omeros Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 160. Omeros Huntington's Disease Treatment Product Portfolios and Specifications
Table 161. Omeros Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Omeros Main Business
Table 163. Omeros Latest Developments
Table 164. Ipsen Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 165. Ipsen Huntington's Disease Treatment Product Portfolios and Specifications
Table 166. Ipsen Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Ipsen Main Business
Table 168. Ipsen Latest Developments
Table 169. Valeant Pharmaceuticals International Inc Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 170. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product Portfolios and Specifications
Table 171. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Valeant Pharmaceuticals International Inc Main Business
Table 173. Valeant Pharmaceuticals International Inc Latest Developments
List of Figures
Figure 1. Picture of Huntington's Disease Treatment
Figure 2. Huntington's Disease Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Huntington's Disease Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Huntington's Disease Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Huntington's Disease Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tetrabenazine
Figure 10. Product Picture of Selective Serotonin Reuptake Inhibitor
Figure 11. Product Picture of Chlorpromazine
Figure 12. Product Picture of Haloperidol
Figure 13. Product Picture of Risperidone
Figure 14. Product Picture of Olanzapine
Figure 15. Product Picture of Clozapine
Figure 16. Product Picture of Other
Figure 17. Global Huntington's Disease Treatment Sales Market Share by Type in 2022
Figure 18. Global Huntington's Disease Treatment Revenue Market Share by Type (2018-2023)
Figure 19. Huntington's Disease Treatment Consumed in Hospital
Figure 20. Global Huntington's Disease Treatment Market: Hospital (2018-2023) & (K Units)
Figure 21. Huntington's Disease Treatment Consumed in Specialty Clinic
Figure 22. Global Huntington's Disease Treatment Market: Specialty Clinic (2018-2023) & (K Units)
Figure 23. Huntington's Disease Treatment Consumed in other
Figure 24. Global Huntington's Disease Treatment Market: other (2018-2023) & (K Units)
Figure 25. Global Huntington's Disease Treatment Sales Market Share by Application (2022)
Figure 26. Global Huntington's Disease Treatment Revenue Market Share by Application in 2022
Figure 27. Huntington's Disease Treatment Sales Market by Company in 2022 (K Units)
Figure 28. Global Huntington's Disease Treatment Sales Market Share by Company in 2022
Figure 29. Huntington's Disease Treatment Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Huntington's Disease Treatment Revenue Market Share by Company in 2022
Figure 31. Global Huntington's Disease Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Huntington's Disease Treatment Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Huntington's Disease Treatment Sales 2018-2023 (K Units)
Figure 34. Americas Huntington's Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 35. APAC Huntington's Disease Treatment Sales 2018-2023 (K Units)
Figure 36. APAC Huntington's Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 37. Europe Huntington's Disease Treatment Sales 2018-2023 (K Units)
Figure 38. Europe Huntington's Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Huntington's Disease Treatment Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Huntington's Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 41. Americas Huntington's Disease Treatment Sales Market Share by Country in 2022
Figure 42. Americas Huntington's Disease Treatment Revenue Market Share by Country in 2022
Figure 43. Americas Huntington's Disease Treatment Sales Market Share by Type (2018-2023)
Figure 44. Americas Huntington's Disease Treatment Sales Market Share by Application (2018-2023)
Figure 45. United States Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Huntington's Disease Treatment Sales Market Share by Region in 2022
Figure 50. APAC Huntington's Disease Treatment Revenue Market Share by Regions in 2022
Figure 51. APAC Huntington's Disease Treatment Sales Market Share by Type (2018-2023)
Figure 52. APAC Huntington's Disease Treatment Sales Market Share by Application (2018-2023)
Figure 53. China Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Huntington's Disease Treatment Sales Market Share by Country in 2022
Figure 61. Europe Huntington's Disease Treatment Revenue Market Share by Country in 2022
Figure 62. Europe Huntington's Disease Treatment Sales Market Share by Type (2018-2023)
Figure 63. Europe Huntington's Disease Treatment Sales Market Share by Application (2018-2023)
Figure 64. Germany Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Huntington's Disease Treatment Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Application (2018-2023)
Figure 73. Egypt Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Huntington's Disease Treatment in 2022
Figure 79. Manufacturing Process Analysis of Huntington's Disease Treatment
Figure 80. Industry Chain Structure of Huntington's Disease Treatment
Figure 81. Channels of Distribution
Figure 82. Global Huntington's Disease Treatment Sales Market Forecast by Region (2024-2029)
Figure 83. Global Huntington's Disease Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Huntington's Disease Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Huntington's Disease Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Huntington's Disease Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Huntington's Disease Treatment Revenue Market Share Forecast by Application (2024-2029)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
